...retired. Each panel was assessed for the inclusion of biomarkers from V.11.2024 NCCN guidelines: ALK, BRAF, EGFR, ERBB, ...
...ret proto-oncogene [RET]; erb-b2 receptor tyrosine kinase 2 [ERBB2] mutations; neurotrophic receptor tyrosine kinase 1, ...
...RET inhibitor, is covered by insurance for all solid tumors that are positive for the RET fusion gene. The RET fusion ge...
...RET fusion has not yet been reported in the medical literature. The HOOK3-RET fusion was observed in a case of α-fetopro...
The receptor tyrosine kinase RET is activated by GDNF and GFRα1 together as a bipartite ligand, driving receptor activat...
...RET, a BRET-based assay reporting direct Gαq recruitment to defined, full-length receptor pairs, we show that signaling ...
...RET therapy but relapsed due to an NTRK1 fusion. Isogenic cell lines expressing MYH10::RET and CCDC6::RET were establish...
...RET, NTRK, and ALK gene fusions, all of which influence prognosis and therapeutic strategies. MTC is primarily driven by...
...RET) exploits endogenous stem cells from the periapical region without ex vivo cell manipulation. Despite growing intere...
Regenerative endodontic treatment (RET) has emerged as a biologically based alternative to traditional apexification for...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269